- Home
- CGEN vs PEBK Comparison
CGEN vs PEBK Comparison
Compare CGEN & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- PEBK
- Stock Information
- Founded
- CGEN 1993
- PEBK 1912
- Country
- CGEN Israel
- PEBK United States
- Employees
- CGEN N/A
- PEBK N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- PEBK Major Banks
- Sector
- CGEN Health Care
- PEBK Finance
- Exchange
- CGEN Nasdaq
- PEBK Nasdaq
- Market Cap
- CGEN 142.8M
- PEBK 169.6M
- IPO Year
- CGEN 2000
- PEBK N/A
- Fundamental
- Price
- CGEN $1.60
- PEBK $32.65
- Analyst Decision
- CGEN Strong Buy
- PEBK
- Analyst Count
- CGEN 2
- PEBK 0
- Target Price
- CGEN $4.00
- PEBK N/A
- AVG Volume (30 Days)
- CGEN 445.1K
- PEBK 29.2K
- Earning Date
- CGEN 11-12-2024
- PEBK 01-21-2025
- Dividend Yield
- CGEN N/A
- PEBK 2.35%
- EPS Growth
- CGEN N/A
- PEBK 1.99
- EPS
- CGEN 0.02
- PEBK 2.95
- Revenue
- CGEN $59,852,000.00
- PEBK $79,995,000.00
- Revenue This Year
- CGEN $57.27
- PEBK N/A
- Revenue Next Year
- CGEN N/A
- PEBK N/A
- P/E Ratio
- CGEN $88.75
- PEBK $11.00
- Revenue Growth
- CGEN 698.03
- PEBK 3.47
- 52 Week Low
- CGEN $1.35
- PEBK $23.74
- 52 Week High
- CGEN $3.03
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- CGEN 51.01
- PEBK 74.23
- Support Level
- CGEN $1.55
- PEBK $31.64
- Resistance Level
- CGEN $1.68
- PEBK $32.64
- Average True Range (ATR)
- CGEN 0.08
- PEBK 0.68
- MACD
- CGEN 0.01
- PEBK -0.08
- Stochastic Oscillator
- CGEN 52.17
- PEBK 70.54
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.